News
Pfizer, BioNTech's mRNA flu vaccine starts phase 3 testing
The first patients have been dosed in a phase 3 trial of an mRNA-based seasonal influenza vaccine developed by Pfizer and BioNTech, which may offer quicker production and greater efficacy t
